Stanford University
Showing 3,951-3,960 of 37,037 Results
-
Blaz Bush
Executive Director -LGBTQ+ Health Program, LGBTQ+
BioWith over a decade of LGBTQ+ affirming healthcare experience from care coordination and program development to education and training, Bláz Bush joined Stanford Medicine as the inaugural Executive Director of the LGBTQ+ Health Program in 2022. Bláz expertly leads strategic growth for the program across the Stanford Medicine Enterprise, represents the program and initiatives to internal and external stakeholders, unifies the multidisciplinary efforts for LGBTQ+ health, develops equitable best practice curriculum and trainings, and facilitates restorative circles for students, faculty, and staff.
-
Leah B. Bushin
Assistant Professor of Chemistry
BioLeah Bushin is a chemical biologist and natural products chemist working at the interface of primary and secondary metabolism and leverages these insights to discover and produce novel natural products.
The Bushin research group will investigate novel metabolic pathways, enzymes, and bioactive molecules across all kingdoms of life, intending to repurpose them to address challenges in human health and environmental sustainability. Current efforts will primarily center on developing strategies for the efficient microbial production of compounds and materials at scale, as well as high-throughput approaches for engineering enzymes to perform synthetic reactions. More broadly, as the group designs and refines bioproduction platforms, they hope to deepen their fundamental understanding of cellular metabolism. With genome sequencing revealing an immense reservoir of untapped biosynthetic potential, their work aims to uncover and harness nature’s chemical diversity for drug discovery and synthetic derivatization. -
Stephan Busque
Professor of Surgery (Abdominal Transplantation), and by courtesy, of Medicine (Nephrology)
On Partial Leave from 04/13/2026 To 06/26/2026Current Research and Scholarly InterestsMy research interest is focused on the improvement of clinical immunosuppression. I am involved in the evaluation of new immunosuppressive drugs, potentially more efficacious or less toxic. My ultimate goal is to achieve tolerance, a state that would obviate the need for any drugs. I am an investigator part of a multidisciplinary tolerance induction project using total lymphoid irradiation and donor hematopoietic stem cells infusion after living donor kidney transplantation.
